Guiling Zhou

Guiling Zhou serves as an Externe medewerker (External Employee) at the University of Groningen's Faculty of Science and Engineering within the Department of PharmacoTherapy, Epidemiology and Economics. Her research critically addresses pandemic-related pharmacological challenges through rigorous epidemiological methodologies.

Dr. Zhou's expertise centers on dynamic intersections of infectious disease control and medication utilization, with signature contributions in:

• Real-world effectiveness of COVID-19 vaccines and repurposed therapeutics
• Longitudinal drug dispensing pattern analysis during public health emergencies
• Systematic reviews of European clinical evidence for health policy
• Pharmacoepidemiological modeling of respiratory disease interventions
• Health technology assessment of oncology and psychiatric medications

Her 2025 publication portfolio reveals concentrated focus on pandemic sequelae—spanning vaccine meta-analyses across European populations, asthma medication trends in young adults, antipsychotic utilization in pediatric cohorts, and NICE appraisal dynamics for lung cancer therapies. This cohesive body demonstrates exceptional methodological range from cohort studies to systematic evidence synthesis.

No scientific awards are documented in current records.

As an emerging researcher post-PhD completion, Dr. Zhou actively supervises through departmental frameworks while leading externally funded projects. Her European collaborative vaccine studies and Dutch healthcare database analyses indicate substantial grant engagement, particularly in pandemic response research infrastructure.

Research operations are integrated within Groningen's PharmacoTherapy department rather than a standalone laboratory, leveraging institutional partnerships with University Medical Center Groningen and European epidemiological networks for population-level data access and multidisciplinary validation.